Standaert headshotIn 2006, Dr. David Standaert was recruited from Harvard Medical School to found a new center for research on neurodegenerative diseases at UAB.  The vision for this center was to support a group of scientists and physician/scientists working to understand the underlying mechanisms of these diseases and developing new therapeutic approaches.  The explicitly translational nature of the new program was captured in its name, the Center for Neurodegeneration and Experimental Therapeutics (CNET).  CNET was officially chartered by the Board of Trustees in February, 2007.

Over the past decade, CNET has grown to a group of 13 laboratories and a staff of over 50.  Active research projects are addressing Alzheimer's disease, frontotemporal dementia, Parkinson's disease, progressive supranuclear palsy, Huntington's disease, and ALS, including three drug discovery projects that have progressed through high-throughput screening.
CNET Retreat 2020